Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
Holding IONS?
Track your performance easily
See the Price Targets and Ratings of:
IONS Analyst Ratings
Strong Buy
12 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IONS Stock 12 Month Forecast
Average Price Target
$61.75
▲(69.04% Upside)
| Highest Price Target$77.00 | Average Price Target$61.75 | Lowest Price Target$45.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
12/23/24
Barclays
Reiterated
12/23/24
TD Cowen
Reiterated
12/20/24
Citi
Reiterated
12/20/24
Needham
Reiterated
12/20/24
Bank of America Securities
Assigned
12/20/24
Leerink Partners
Reiterated
12/20/24
Oppenheimer
Reiterated
12/10/24
Raymond James
Reiterated
12/02/24
J.P. Morgan
Reiterated
11/27/24
Stifel Nicolaus
$45
Hold
23.19%
Upside
Reiterated
11/07/24
Stifel Nicolaus Sticks to Its Hold Rating for Ionis Pharmaceuticals (IONS)
Wells Fargo
$77
Buy
110.79%
Upside
Assigned
11/07/24
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS), Sarepta Therapeutics (NASDAQ: SRPT) and Cytokinetics (NASDAQ: CYTK)
Morgan Stanley
$55
Hold
50.56%
Upside
Reiterated
11/07/24
Ionis Pharmaceuticals: Hold Rating Maintained Amid Mixed Financial Performance and Promising Future Prospects
RBC Capital
$70
Buy
91.62%
Upside
Reiterated
11/06/24
RBC Capital Sticks to Their Buy Rating for Ionis Pharmaceuticals (IONS)
Guggenheim
$70→$65
Buy
77.94%
Upside
Reiterated
10/09/24
Ionis Pharmaceuticals price target lowered to $65 from $70 at GuggenheimIonis Pharmaceuticals price target lowered to $65 from $70 at Guggenheim
Best Analysts Covering Ionis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy IONS and Sell After:
1 Month
xxx
Success Rate
11/16 ratings generated profit
Average Return
+2.34%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.75% of your transactions generating a profit, with an average return of +2.34% per trade.
3 Months
xxx
Success Rate
17/28 ratings generated profit
Average Return
+2.38%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +2.38% per trade.
1 Year
Success Rate
12/16 ratings generated profit
Average Return
+15.44%
reiterated a buy rating 24 days ago
Copying Gary Nachman's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +15.44% per trade.
2 Years
xxx
Success Rate
12/16 ratings generated profit
Average Return
+20.09%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +20.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IONS Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
7
8
8
12
18
Buy
14
12
7
2
1
Hold
12
8
6
5
6
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
34
29
22
19
25
Each month's total comprises the sum of three months' worth of ratings.
IONS Financial Forecast
IONS Stock Forecast FAQ
What is IONS’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is $61.75.
What is IONS’s upside potential, based on the analysts’ average price target?
Ionis Pharmaceuticals has 69.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IONS a Buy, Sell or Hold?
Ionis Pharmaceuticals has a consensus rating of Strong Buy which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.
What is Ionis Pharmaceuticals’s price target?
The average price target for Ionis Pharmaceuticals is $61.75. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $77.00 ,the lowest forecast is $45.00. The average price target represents 69.04% Increase from the current price of $36.53.
The highest analyst price target is $77.00 ,the lowest forecast is $45.00. The average price target represents 69.04% Increase from the current price of $36.53.
What do analysts say about Ionis Pharmaceuticals?
Ionis Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of IONS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.